The underwriter's full exercise of its option to purchase additional shares and warrants increases the total gross proceeds from the offering to $10.8 million. This additional capital will help fund Modular Medical's operations, R&D, sales and marketing infrastructure, and manufacturing capabilities. The news is likely to have a positive short-term impact on the stock price as it demonstrates confidence in the company and provides additional resources for growth.